Search
Nektar Therapeutics
NKTRAdd to Watchlist
68.874USD
-1.796-2.54%
Market hours （ET）Quotes delayed by 15 min
2.03BMarket Cap
LossP/E TTM
NKTR Income Statement
You can find the annual or quarterly income statement of Nektar Therapeutics here for insights into the performance and operational efficiency of Nektar Therapeutics.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
How do I read Nektar Therapeutics's income statement on TradingKey?
Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.
What is the difference between quarterly and annual income statements?
A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.
What does YOY mean on the income statement page?
YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.
Which income statement metrics matter most when analyzing NKTR stock?
Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.
What was Nektar Therapeutics's revenue at year end?
Nektar Therapeutics reported 55.23M in revenue for fiscal year 2025, up from 98.43M in the previous year.
How much revenue did Nektar Therapeutics report in the most recent quarter?
Nektar Therapeutics reported 10.86M in revenue for the most recent quarter, an increase of 3.83% year over year.
What was Nektar Therapeutics's net income for the year?
Nektar Therapeutics posted -164.08M in net income for fiscal year 2025.
How much net income did Nektar Therapeutics post in the last quarter?
Nektar Therapeutics reported -44.90M in net income for the latest quarter。
What was Nektar Therapeutics's annual operating profit?
Nektar Therapeutics's operating income was -130.77M for fiscal year 2025.
How is EPS related to the income statement?
EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.